Researchers evaluate effectiveness of biologics on bio-naïve and bio-experienced PsO patients

In a recent study, researchers identify biologics for psoriasis that have better drug survival in bio-naïve or bio-experienced patients—a finding they hope can guide treatment choice in clinical practice.